Understanding the Context of the “Natural Inclinations” and the Natural Law in Summa Theologiae I–II, q. 94, a. 2
American Catholic Philosophical Quarterly · 2025 · 99 (4) · 519-535
DOI: 10.5840/acpq2025994324 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Catholic Philosophical Quarterly, 2025. Verfasst von Randall B. Smith.
Abstract (Originalsprache)
There have been multiple interpretations of Thomas’s account of the “inclinations” in ST I–II, q. 94, a. 2, some of which turn them into the basis of an entire ethical system. I argue in what follows, that these “inclinations” should be understood in the context of the discussions carried on in the twelfth century among the decretists about the different levels of “nature” and “law.” Thomas uses a passage from Cicero’s De officiis to help him organize this material more coherently. I also point out why it is essential that we not separate Thomas’s discussion of the natural law from his later accounts of the divine law, especially his discussion of the moral precepts of the Old Law which, according to Thomas, reveal the fundamental precepts of the natural law, or from his extended discussion in the secunda secundae of the virtues, much of which is also borrowed from Cicero.
Zitieren
APA
Smith, R. B. (2025). Understanding the Context of the “Natural Inclinations” and the Natural Law in Summa Theologiae I–II, q. 94, a. 2. American Catholic Philosophical Quarterly, 99(4), 519-535. https://doi.org/10.5840/acpq2025994324
Vancouver
Smith RB. Understanding the Context of the “Natural Inclinations” and the Natural Law in Summa Theologiae I–II, q. 94, a. 2. American Catholic Philosophical Quarterly. 2025;99(4):519-535. doi:10.5840/acpq2025994324
BibTeX
@article{Smith2025,
author = {Smith, Randall B.},
title = {Understanding the Context of the “Natural Inclinations” and the Natural Law in Summa Theologiae I–II, q. 94, a. 2},
journal = {American Catholic Philosophical Quarterly},
year = {2025},
volume = {99},
number = {4},
pages = {519--535},
doi = {10.5840/acpq2025994324}
}
EUVIMED